ATE237680T1 - Transplantation von hämatopoietischen zellen - Google Patents

Transplantation von hämatopoietischen zellen

Info

Publication number
ATE237680T1
ATE237680T1 AT00905194T AT00905194T ATE237680T1 AT E237680 T1 ATE237680 T1 AT E237680T1 AT 00905194 T AT00905194 T AT 00905194T AT 00905194 T AT00905194 T AT 00905194T AT E237680 T1 ATE237680 T1 AT E237680T1
Authority
AT
Austria
Prior art keywords
transplantation
hematopoietic cells
disease
treatment
stem cells
Prior art date
Application number
AT00905194T
Other languages
English (en)
Inventor
Jack Price
Original Assignee
Reneuron Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reneuron Ltd filed Critical Reneuron Ltd
Application granted granted Critical
Publication of ATE237680T1 publication Critical patent/ATE237680T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/04—Immortalised cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Psychology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
AT00905194T 1999-02-24 2000-02-23 Transplantation von hämatopoietischen zellen ATE237680T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9904281.4A GB9904281D0 (en) 1999-02-24 1999-02-24 Transplantation
PCT/GB2000/000636 WO2000050568A2 (en) 1999-02-24 2000-02-23 Transplantation of haematopoietic cells

Publications (1)

Publication Number Publication Date
ATE237680T1 true ATE237680T1 (de) 2003-05-15

Family

ID=10848438

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00905194T ATE237680T1 (de) 1999-02-24 2000-02-23 Transplantation von hämatopoietischen zellen

Country Status (20)

Country Link
EP (1) EP1161521B1 (de)
JP (1) JP4716575B2 (de)
KR (1) KR20020000216A (de)
CN (1) CN1636053A (de)
AT (1) ATE237680T1 (de)
AU (1) AU762763B2 (de)
CA (1) CA2361401A1 (de)
CZ (1) CZ20012651A3 (de)
DE (1) DE60002185T2 (de)
DK (1) DK1161521T3 (de)
ES (1) ES2193938T3 (de)
GB (1) GB9904281D0 (de)
HK (1) HK1041284B (de)
HU (1) HUP0105168A3 (de)
NO (1) NO20014091D0 (de)
PL (1) PL350297A1 (de)
PT (1) PT1161521E (de)
RU (1) RU2216336C2 (de)
SK (1) SK11232001A3 (de)
WO (1) WO2000050568A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9518606D0 (en) 1995-09-12 1995-11-15 Inst Of Psychiatry Neural transplantation
US8017112B2 (en) 1999-05-14 2011-09-13 Henry Ford Health System Transplantation of bone marrow stromal cells for treatment of neurodegenerative diseases
WO2000069448A1 (en) * 1999-05-14 2000-11-23 Henry Ford Health System Bone marrow transplantation for treatment of stroke
WO2003060082A2 (en) * 2002-01-14 2003-07-24 The Board Of Trustees Of The University Of Illinois Use of modified pyrimidine compounds to promote stem cell migration and proliferation
JPWO2004045666A1 (ja) * 2002-11-15 2006-03-16 株式会社産学連携機構九州 臓器の再生方法
DE602005002430T2 (de) 2004-09-30 2008-06-19 Reneuron Ltd., Guildford Zelllinie
RU2283119C1 (ru) * 2005-03-29 2006-09-10 Андрей Степанович БРЮХОВЕЦКИЙ Препарат аутологичных гемопоэтических стволовых клеток, способ его получения, криоконсервации и использования для лечения травматической болезни центральной нервной системы
US7569545B2 (en) * 2005-05-20 2009-08-04 Academia Sinica Methods of increasing neurotrophic factor expression
WO2007112084A2 (en) 2006-03-24 2007-10-04 Children's Medical Center Corporation Method to modulate hematopoietic stem cell growth
WO2008070310A2 (en) 2006-10-20 2008-06-12 Children's Medical Center Corporation Method to enhance tissue regeneration
CA2736018C (en) 2008-09-16 2015-11-03 Stephanie Merchant Compositions for treating or delaying the onset of hair loss
WO2010096264A2 (en) 2009-02-03 2010-08-26 Children's Medical Center Corporation Methods for enhancing hematopoietic stem/progenitor cell engraftment
WO2010091052A2 (en) 2009-02-03 2010-08-12 Children's Medical Center Corporation Methods for enhancing hematopoietic stem/progenitor cell engraftment
GB0902034D0 (en) 2009-02-06 2009-03-11 Reneuron Ltd Method
RU2611396C2 (ru) * 2011-04-20 2017-02-21 Де Реджентс Оф Де Юниверсити Оф Калифорния Способ совместного кондиционирования и хемоселекции за один цикл
ES2682255T3 (es) 2011-12-02 2018-09-19 Fate Therapeutics, Inc. Métodos mejorados de tratamiento de isquemia
AU2012321088B8 (en) 2011-12-02 2016-12-15 Fate Therapeutics, Inc. Enhanced stem cell composition
EP2968416A4 (de) 2013-03-15 2016-08-17 Fate Therapeutics Inc Zellpotenztest für therapeutisches potenzial
RU2647429C1 (ru) * 2017-02-06 2018-03-15 Федеральное государственное автономное образовательное учреждение высшего образования "Дальневосточный федеральный университет" (ДВФУ) Биомедицинский клеточный препарат
RU2720002C1 (ru) * 2018-12-28 2020-04-23 Андрей Степанович БРЮХОВЕЦКИЙ Биомедицинский клеточный продукт для лечения нервных болезней и психических расстройств, способ его получения и его применение
CN114934072B (zh) * 2022-05-18 2023-10-20 华中科技大学同济医学院附属协和医院 一种人心脏瓣膜间质细胞系的永生化构建方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399493A (en) * 1989-06-15 1995-03-21 The Regents Of The University Of Michigan Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
US5612211A (en) * 1990-06-08 1997-03-18 New York University Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors
KR950700403A (ko) * 1992-03-04 1995-01-16 죤 제이. 쉬바르츠 조혈 간세포의 배양 및 그것의 유전공학(culturing of hematopoietic stem cells and their genetic engineering)
TR199701711T1 (xx) * 1995-06-27 1998-05-21 Boehringer Ingelheim Kg. Aerosollerin imalat� i�in yeni stabil ila� bile�imleri.
GB9518606D0 (en) * 1995-09-12 1995-11-15 Inst Of Psychiatry Neural transplantation
NZ334016A (en) * 1996-08-19 2000-08-25 Univ Massachusetts Embryonic stem cell lines produced by cross species nuclear transplantation

Also Published As

Publication number Publication date
PT1161521E (pt) 2003-08-29
KR20020000216A (ko) 2002-01-05
WO2000050568A3 (en) 2000-12-07
PL350297A1 (en) 2002-12-02
EP1161521A2 (de) 2001-12-12
AU2682100A (en) 2000-09-14
HK1041284A1 (en) 2002-07-05
HUP0105168A3 (en) 2003-12-29
JP2002537406A (ja) 2002-11-05
NO20014091L (no) 2001-08-23
RU2216336C2 (ru) 2003-11-20
CA2361401A1 (en) 2000-08-31
HK1041284B (zh) 2003-10-03
DE60002185D1 (de) 2003-05-22
JP4716575B2 (ja) 2011-07-06
CZ20012651A3 (cs) 2002-01-16
EP1161521B1 (de) 2003-04-16
DK1161521T3 (da) 2003-06-16
CN1636053A (zh) 2005-07-06
ES2193938T3 (es) 2003-11-16
NO20014091D0 (no) 2001-08-23
WO2000050568A2 (en) 2000-08-31
AU762763B2 (en) 2003-07-03
SK11232001A3 (sk) 2002-01-07
GB9904281D0 (en) 1999-04-21
HUP0105168A2 (hu) 2002-05-29
DE60002185T2 (de) 2003-12-18

Similar Documents

Publication Publication Date Title
ATE237680T1 (de) Transplantation von hämatopoietischen zellen
DE60231708D1 (de) Somatische pluripotente Zellen
NO20004803L (no) Smilagening og anzurogenin for behandling av Alzheimers sykdom
GB0400167D0 (en) Dopaminergic neurons and proliferation-competent orecursor cells for treating parkinson's disease
GT199600026A (es) Isotiazolonas
SE9900100D0 (sv) New compounds
CA2336833A1 (en) Remedy with antidepressant effects
DE60044793D1 (de) In-vitro Herstellung von transplantierbarem Knorpelgewebe
DE59603216D1 (de) Esterquats und ihre Verwendung zur Herstellung von oberflächenaktiven Mitteln, insbesondere zur Haar- und Körperpflege
WO2003105725A3 (en) ARTIFICIAL CORNEA
BR0207775A (pt) Lipossomos anfotéricos métodos para carregamento dos mesmos com ingredientes ativos e sua utilização
ATE373835T1 (de) Progressive additionslinsen
TR199701212T1 (xx) �drar� tutamama halinin tedavisi i�in alfa IL- agonistlerinin kullan�lmas�.
WO2003039454A3 (en) Beta-secretase inhibitors and methods of use
WO2003102016A3 (en) Amyloid peptide inactivating enzyme to treat alzheimer's disease
WO1998013488A3 (en) Process for the determination of app secretase modulators and the use thereof as agents in the treatment of alzheimer's disease
HK1080408B (zh) 溴莫尼定在治療痴呆和帕金森病中的用途
NO995440D0 (no) Ny klasse fotoaktive benzoporfyrinderivat-forbindelser
DE59406417D1 (de) Bauteilsatz zur herstellung eines wurzelraumschutzes
DE60043888D1 (de) Oberfläche für zellkultur
DE50010234D1 (de) Verwendung von desoxypeganin zur behandlung von alzheimerischer demenz
BR0114884A (pt) Compostos calcilìticos
DE69700085T2 (de) N-(Alkyloxycarbonyl)-N-(2-hydroxy-3-alkyloxypropyl)-ethanolamin-Derivate und ihre Verwendung in und zur Herstellung von kosmetischen oder dermatologischen Zusammensetzungen
RU2002116475A (ru) Способ лечения паркинсонизма и болезни паркинсона
SE9704458D0 (sv) Anläggning samt förfarande vid en sådan, del 2

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1161521

Country of ref document: EP

REN Ceased due to non-payment of the annual fee